Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents-Reference-Cited by-同舟云学术

Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents

Published:2020-10-20 Issue: Volume: Page:1-14
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Marques Emanuel¹²^ORCID,Paluch Zoltán²³,Boháč Petr⁴,Slanař Ondřej⁵,Běláček Jaromír⁶,Hercogová Jana⁴⁷

Affiliation:

1. Department of Dermatovenerology, Faculty Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic

2. Department of Pharmacology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

3. St. John Nepomucene Neumann Institute, Příbram, Czech Republic; St. Elisabeth University of Health Care and Social Work, Bratislava, Slovak Republic

4. Department of Dermatovenerology, Na Bulovce Hospital, Second Faculty of Medicine, Charles University, Prague, Czech Republic

5. Department of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic

6. Department of Statistics and Operation Analysis, Faculty of Business and Economics of Brno, Mendel University, Brno, Czech Republic

7. Department of Dermatovenerology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1826393

Reference75 articles.

1. Psoriasis and its management

2. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

3. The economic impact of psoriasis increases with psoriasis severity

4. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database

5. CLinical experience acquired with the efalizumab (Raptiva® ) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?;Journal of the European Academy of Dermatology and Venereology;2024-07-30

2. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-interleukin-17A monoclonal antibody: an observational study;Scientific Reports;2024-07-02

3. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-interleukin-17A monoclonal antibody: an observational study;2024-02-22

4. Does biological agent treatment have an impact on serum uric acid levels in patients with psoriasis?;Current Medical Research and Opinion;2023-09-29